Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABEMACICLIB Cause Red cell distribution width increased? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Red cell distribution width increased have been filed in association with ABEMACICLIB (Verzenio). This represents 0.0% of all adverse event reports for ABEMACICLIB.

7
Reports of Red cell distribution width increased with ABEMACICLIB
0.0%
of all ABEMACICLIB reports
2
Deaths
1
Hospitalizations

How Dangerous Is Red cell distribution width increased From ABEMACICLIB?

Of the 7 reports, 2 (28.6%) resulted in death, 1 (14.3%) required hospitalization.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ABEMACICLIB Cause?

Diarrhoea (4,988) Fatigue (1,878) Nausea (1,682) Vomiting (943) Malignant neoplasm progression (890) Decreased appetite (744) Death (696) Asthenia (678) Drug ineffective (668) White blood cell count decreased (566)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) ADALIMUMAB (144) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108)

Which ABEMACICLIB Alternatives Have Lower Red cell distribution width increased Risk?

ABEMACICLIB vs ABILIFY ABEMACICLIB vs ABIRATERONE ABEMACICLIB vs ABIRATERONE\ABIRATERONE ABEMACICLIB vs ABOBOTULINUMTOXINA ABEMACICLIB vs ABRAXANE

Related Pages

ABEMACICLIB Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased ABEMACICLIB Demographics